The effects of pleiotrophin in proliferative diabetic retinopathy

PLoS ONE

Volumn 10, Issue 1, 2015, Pages

  Zhu, Xuemei ^a   Bai, Yujing ^a   Yu, Wenzhen ^a   Pan, Chungting ^a   Jin, Enzhong ^a   Song, Dan ^a   Xu, Qiong ^a   Yao, Yuou ^a   Huang, Lvzhen ^a   Tao, Yong ^a   Li, Xiaoxin ^a   Zhao, Mingwei ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLEIOTROPHIN; VASCULOTROPIN; CARRIER PROTEIN; CYTOKINE; NERVE GROWTH FACTOR; VASCULOTROPIN A;

ADULT; APOPTOSIS; ARTICLE; CELL ADHESION; CELL CYCLE ARREST; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; ENZYME PHOSPHORYLATION; EPIRETINAL MEMBRANE; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HYPERGLYCEMIA; HYPOXIA; IN VITRO STUDY; MALE; PATHOGENESIS; PIGMENT EPITHELIUM; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; AGED; CELL HYPOXIA; COMPLICATION; ENDOTHELIUM CELL; GENETICS; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; RETINAL PIGMENT EPITHELIUM; RNA INTERFERENCE; VITREOUS BODY;

AGED; CARRIER PROTEINS; CELL ADHESION; CELL HYPOXIA; CELL PROLIFERATION; CYTOKINES; DIABETIC RETINOPATHY; ENDOTHELIAL CELLS; EPIRETINAL MEMBRANE; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOVASCULARIZATION, PATHOLOGIC; NERVE GROWTH FACTORS; RETINAL PIGMENT EPITHELIUM; RNA INTERFERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS BODY;

EID: 84921898421     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0115523     Document Type: Article

References (52)

1. Zhang X, Saaddine JB, Chou CF, Cotch MF, Cheng YJ, et al. (2010) Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA 304: 649-656. doi: 10.1001/jama.2010.1111 PMID: 20699456
2. Heng LZ, Comyn O, Peto T, Tadros C, Ng E, et al. (2013) Diabetic retinopathy: pathogenesis, clinical grading, management and future developments. Diabet Med 30: 640-650. doi: 10.1111/dme.12089 PMID: 23205608
3. Wong TY, Cheung N, Tay WT, Wang JJ, Aung T, et al. (2008) Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology 115: 1869-1875. PMID: 18584872
4. Busik JV, Mohr S, Grant MB (2008) Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators. Diabetes 57: 1952-1965. doi: 10.2337/db07-1520 PMID: 18420487
5. Geraldes P, Hiraoka-Yamamoto J, Matsumoto M, Clermont A, Leitges M, et al. (2009) Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy. Nat Med 15: 1298-1306. doi: 10.1038/nm.2052 PMID: 19881493
6. Saker S, Stewart EA, Browning AC, Allen CL, AmoakuWM(2014) The effect of hyperglycaemia on permeability and the expression of junctional complex molecules in human retinal and choroidal endothelial cells. Exp Eye Res 121: 161-167. doi: 10.1016/j.exer.2014.02.016 PMID: 24594192
7. Chen M, Curtis TM, Stitt AW (2013) Advanced glycation end products and diabetic retinopathy. Curr Med Chem 20: 3234-3240. PMID: 23745547
8. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, et al. (1998) Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 102: 783-791. doi: 10.1172/JCI2425 PMID: 9710447
9. Mizutani M, Gerhardinger C, Lorenzi M (1998) Muller cell changes in human diabetic retinopathy. Diabetes 47: 445-449. PMID: 9519752
10. Jindal V (2014) Neurodegeneration as a Primary Change and Role of Neuroprotection in Diabetic Retinopathy. Mol Neurobiol.
11. Feit-Leichman RA, Kinouchi R, Takeda M, Fan Z, Mohr S, et al. (2005) Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. Invest Ophthalmol Vis Sci 46: 4281-4287. PMID: 16249509
12. Barber AJ, Gardner TW, Abcouwer SF (2011) The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. Invest Ophthalmol Vis Sci 52: 1156-1163. doi: 10.1167/iovs.10-6293 PMID: 21357409
13. Jung KI, Kim JH, Park HY, Park CK (2013) Neuroprotective effects of cilostazol on retinal ganglion cell damage in diabetic rats. J Pharmacol Exp Ther 345: 457-463. doi: 10.1124/jpet.113.203067 PMID: 23536314
14. Li P. Xu X. Zheng Z. Zhu B. Shi Y.et al2011Protective effects of rosiglitazone on retinal neuronal damage in diabetic ratsCurr Eye Res36673-67910.3109/02713683.2011.572220PMID: 21599458
15. Li P, Xu X, Zheng Z, Zhu B, Shi Y, et al. (2011) Protective effects of rosiglitazone on retinal neuronal damage in diabetic rats. Curr Eye Res 36: 673-679. doi: 10.3109/02713683.2011.572220 PMID: 21599458 15. (1991) Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 98: 766-785. PMID: 2062512
16. rd (1991) Photocoagulation for diabetic retinopathy. Early Treatment Diabetic Retinopathy Study Research Group. JAMA 266: 1263-1265. PMID: 1870253
17. Simo R, Hernandez C (2009) Advances in the medical treatment of diabetic retinopathy. Diabetes Care 32: 1556-1562. doi: 10.2337/dc09-0565 PMID: 19638526
18. Osaadon P, Fagan XJ, Lifshitz T, Levy J (2014) A review of anti-VEGF agents for proliferative diabetic retinopathy. Eye (Lond) 28: 510-520. doi: 10.1038/eye.2014.13 PMID: 24525867
19. Cheung N, Wong IY, Wong TY (2014) Ocular anti-VEGF therapy for diabetic retinopathy: overview of clinical efficacy and evolving applications. Diabetes Care 37: 900-905. doi: 10.2337/dc13-1990 PMID: 24652721
20. Deuel TF, Zhang N, Yeh HJ, Silos-Santiago I, Wang ZY (2002) Pleiotrophin: a cytokine with diverse functions and a novel signaling pathway. Arch Biochem Biophys 397: 162-171. PMID: 11795867
21. Bloch B, Normand E, Kovesdi I, Bohlen P (1992) Expression of the HBNF (heparin-binding neuritepromoting factor) gene in the brain of fetal, neonatal and adult rat: an in situ hybridization study. Brain Res Dev Brain Res 70: 267-278. PMID: 1477961
22. Zhang N, Zhong R, Wang ZY, Deuel TF (1997) Human breast cancer growth inhibited in vivo by a dominant negative pleiotrophin mutant. J Biol Chem 272: 16733-16736. PMID: 9201975
23. Mentlein R, Held-Feindt J (2002) Pleiotrophin, an angiogenic and mitogenic growth factor, is expressed in human gliomas. J Neurochem 83: 747-753. PMID: 12421346
24. Weber D, Klomp HJ, Czubayko F, Wellstein A, Juhl H (2000) Pleiotrophin can be rate-limiting for pancreatic cancer cell growth. Cancer Res 60: 5284-5288. PMID: 11016659
25. Perez-Pinera P, Alcantara S, Dimitrov T, Vega JA, Deuel TF (2006) Pleiotrophin disrupts calciumdependent homophilic cell-cell adhesion and initiates an epithelial-mesenchymal transition. Proc Natl Acad Sci U S A 103: 17795-17800. doi: 10.1073/pnas.0607299103
26. Chang Y, Zuka M, Perez-Pinera P, Astudillo A, Mortimer J, et al. (2007) Secretion of pleiotrophin stimulates breast cancer progression through remodeling of the tumor microenvironment. Proc Natl Acad Sci U S A 104: 10888-10893. doi: 10.1073/pnas.0704366104
27. Yao J, Hu XF, Feng XS, Gao SG (2013) Pleiotrophin promotes perineural invasion in pancreatic cancer. World J Gastroenterol 19: 6555-6558.
28. Czubayko F, Riegel AT, Wellstein A (1994) Ribozyme-targeting elucidates a direct role of pleiotrophin in tumor growth. J Biol Chem 269: 21358-21363. PMID: 8063762
29. Kohashi T, Tateaki Y, Tateno C, Asahara T, Obara M, et al. (2002) Expression of pleiotrophin in hepatic nonparenchymal cells and preneoplastic nodules in carbon tetrachloride-induced fibrotic rat liver. Growth Factors 20: 53-60. PMID: 11999218
30. Zhang Q, Tao K, Huang W, Tian Y, Liu X (2013) Elevated expression of pleiotrophin in human hypertrophic scars. J Mol Histol 44: 91-96. PMID: 23054143
31. Pufe T, Bartscher M, PetersenW, Tillmann B, Mentlein R (2003) Expression of pleiotrophin, an embryonic growth and differentiation factor, in rheumatoid arthritis. Arthritis Rheum 48: 660-667. PMID: 12632418
32. Yokoi H, Kasahara M, Mori K, Ogawa Y, Kuwabara T, et al. (2012) Pleiotrophin triggers inflammation and increased peritoneal permeability leading to peritoneal fibrosis. Kidney Int 81: 160-169. doi: 10. 1038/ki.2011.305 PMID: 21881556
33. Herradon G, Perez-Garcia C (2014) Targeting midkine and pleiotrophin signalling pathways in addiction and neurodegenerative disorders: recent progress and perspectives. Br J Pharmacol 171: 837-848. doi: 10.1111/bph.12312 PMID: 23889475
34. Li YS, Milner PG, Chauhan AK, Watson MA, Hoffman RM, et al. (1990) Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. Science 250: 1690-1694. PMID: 2270483
35. Rumsby M, Suggitt F, Haynes L, Hughson E, Kidd D, et al. (1999) Substratum of pleiotrophin (HBGAM) stimulates rat CG-4 line oligodendrocytes to adopt a bipolar morphology and disperse: primary O-2A progenitor glial cells disperse similarly on pleiotrophin. Glia 26: 361-367. PMID: 10383055
36. Hida H, Jung CG, Wu CZ, Kim HJ, Kodama Y, et al. (2003) Pleiotrophin exhibits a trophic effect on survival of dopaminergic neurons in vitro. Eur J Neurosci 17: 2127-2134. PMID: 12786979
37. Herradon G, Ezquerra L (2009) Blocking receptor protein tyrosine phosphatase beta/zeta: a potential therapeutic strategy for Parkinson's disease. Curr Med Chem 16: 3322-3329. PMID: 19548869
38. Bai Y, Yu W, Han N, Yang F, Sun Y, et al. (2013) Effects of semaphorin 3A on retinal pigment epithelial cell activity. Invest Ophthalmol Vis Sci 54: 6628-6638. doi: 10.1167/iovs.13-12625 PMID: 24045994
39. Yu W, Bai Y, Han N, Wang F, Zhao M, et al. (2013) Inhibition of pathological retinal neovascularization by semaphorin 3A. Mol Vis 19: 1397-1405. PMID: 23825919
40. Miao J, Ding M, Zhang A, Xiao Z, Qi W, et al. (2012) Pleiotrophin promotes microglia proliferation and secretion of neurotrophic factors by activating extracellular signal-regulated kinase 1/2 pathway. Neurosci Res 74: 269-276. doi: 10.1016/j.neures.2012.09.001 PMID: 23000062
41. Ye X, Xu G, Chang Q, Fan J, Sun Z, et al. (2010) ERK1/2 signaling pathways involved in VEGF release in diabetic rat retina. Invest Ophthalmol Vis Sci 51: 5226-5233. doi: 10.1167/iovs.09-4899 PMID: 20445124
42. Isenovic ER, Kedees MH, Haidara MA, Trpkovic A, Mikhailidis DP, et al. (2010) Involvement of ERK1/2 kinase in insulin-and thrombin-stimulated vascular smooth muscle cell proliferation. Angiology 61: 357-364. doi: 10.1177/0003319709358693 PMID: 20304866
43. Tsai TT, Ho NY, Lin YT, Lai PL, Fu TS, et al. (2014) Advanced glycation end products in degenerative nucleus pulposus with diabetes. J Orthop Res 32: 238-244. PMID: 24151186
44. D'Amico AG, Scuderi S, Maugeri G, Cavallaro S, Drago F, et al. (2014) NAP Reduces Murine Microvascular Endothelial Cells Proliferation Induced by Hyperglycemia. J Mol Neurosci. doi: 10.1007/s12031-014-0335-2 PMID: 24874579
45. Christman KL, Fang Q, Yee MS, Johnson KR, Sievers RE, et al. (2005) Enhanced neovasculature formation in ischemic myocardium following delivery of pleiotrophin plasmid in a biopolymer. Biomaterials 26: 1139-1144. PMID: 15451633
46. Li J, Wei H, Chesley A, Moon C, Krawczyk M, et al. (2007) The pro-angiogenic cytokine pleiotrophin potentiates cardiomyocyte apoptosis through inhibition of endogenous AKT/PKB activity. J Biol Chem 282: 34984-34993. PMID: 17925408
47. Kong Y, Bai PS, Nan KJ, Sun H, Chen NZ, et al. (2012) Pleiotrophin is a potential colorectal cancer prognostic factor that promotes VEGF expression and induces angiogenesis in colorectal cancer. Int J Colorectal Dis 27: 287-298. doi: 10.1007/s00384-011-1344-z PMID: 22065111
48. Deuel TF (2013) Anaplastic lymphoma kinase: " Ligand Independent Activation" mediated by the PTN/ RPTPbeta/zeta signaling pathway. Biochim Biophys Acta 1834: 2219-2223. doi: 10.1016/j.bbapap. 2013.06.004 PMID: 23777859
49. Bowden ET, Stoica GE, Wellstein A (2002) Anti-apoptotic signaling of pleiotrophin through its receptor, anaplastic lymphoma kinase. J Biol Chem 277: 35862-35868. PMID: 12107166
50. Fan JB, Liu W, Yuan K, Zhu XH, Xu DW, et al. (2014) EGFR trans-activation mediates pleiotrophin-induced activation of Akt and Erk in cultured osteoblasts. Biochem Biophys Res Commun 447: 425-430. doi: 10.1016/j.bbrc.2014.04.002 PMID: 24727451
51. Koutsioumpa M, Polytarchou C, Courty J, Zhang Y, Kieffer N, et al. (2013) Interplay between alphavbeta3 integrin and nucleolin regulates human endothelial and glioma cell migration. J Biol Chem 288: 343-354. doi: 10.1074/jbc.M112.387076 PMID: 23161541
52. Liu J, Wu X, Liu Y, Xu Y, Huang Y, et al. (2013) High-glucose-based peritoneal dialysis solution induces the upregulation of VEGF expression in human peritoneal mesothelial cells: The role of pleiotrophin. Int J Mol Med 32: 1150-1158. doi: 10.3892/ijmm.2013.1491 PMID: 24042838